Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Inventory (2016 - 2025)

Immucell's Inventory history spans 16 years, with the latest figure at $9.3 million for Q4 2025.

  • For Q4 2025, Inventory rose 30.29% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $9.3 million, up 30.29%, while the annual FY2025 figure was $9.3 million, 30.29% up from the prior year.
  • Inventory reached $9.3 million in Q4 2025 per ICCC's latest filing, down from $9.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $9.8 million in Q3 2025 to a low of $2.1 million in Q1 2021.
  • Average Inventory over 5 years is $6.1 million, with a median of $7.1 million recorded in 2024.
  • Peak YoY movement for Inventory: soared 99.39% in 2022, then decreased 8.95% in 2024.
  • A 5-year view of Inventory shows it stood at $3.1 million in 2021, then surged by 95.42% to $6.0 million in 2022, then grew by 29.37% to $7.8 million in 2023, then fell by 8.95% to $7.1 million in 2024, then surged by 30.29% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Inventory are $9.3 million (Q4 2025), $9.8 million (Q3 2025), and $8.3 million (Q2 2025).